Skip to search formSkip to main contentSkip to account menu

SR 146131

Known as: SR-146131, SR146131 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Allosteric modulation of receptors provides mechanistic safety while effectively achieving biologic endpoints otherwise difficult… 
2002
2002
Abstract Rationale. Converging evidence has demonstrated that cholecystokinin (CCK) inhibits mesolimbic brain dopamine (DA… 
1999
1999
SR146131 inhibited the binding of [125I]-Bolton Hunter (BH)-sulfated cholecystokinin octapeptide (CCK-8S) for the human… 
1999
1999
SR146131 is a potent and selective agonist at cholecystokinin subtype 1 (CCK1) receptors in vitro. The present study evaluates…